Peg‐interferon and nucleos(t)ide analogue combination at inception of antiviral therapy improves both anti‐HBV efficacy and long‐term survival among HBV DNA‐positive hepatocellular carcinoma patients after hepatectomy/ablation-Reference-Cited by-同舟云学术

Peg‐interferon and nucleos(t)ide analogue combination at inception of antiviral therapy improves both anti‐HBV efficacy and long‐term survival among HBV DNA‐positive hepatocellular carcinoma patients after hepatectomy/ablation

Published:2019-12-11 Issue:4 Volume:27 Page:387-396
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Qi Wenqian¹,Zhang Qian¹,Xu Yan¹,Wang Xu¹,Yu Fan¹,Zhang Yonggui¹,Zhao Ping¹,Guo Honghua¹,Zhou Changyu¹,Wang Zhe¹,Sun Yu²,Liu Lin²,Xuan Wei³,Wang Jiangbin¹^ORCID

Affiliation:

1. Digestive Department China‐Japan Union Hospital of Jilin University Changchun China

2. Invasive Technology Department China‐Japan Union Hospital of Jilin University Changchun China

3. Hepatobiliary Surgery China‐Japan Union Hospital of Jilin University Changchun China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13236